ZYNE - Zynerba Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ZYNE is currently covered by 2 analysts with an average price target of $6.73. This is a potential upside of $5.43 (417.69%) from yesterday's end of day stock price of $1.3.

Zynerba Pharmaceuticals's activity chart (see below) currently has 48 price targets and 43 ratings on display. The stock rating distribution of ZYNE is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.02% with an average time for these price targets to be met of 103.5 days.

Highest price target for ZYNE is $1.11, Lowest price target is $1.11, average price target is $6.73.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.

Currently out of the existing stock ratings of ZYNE, 2 are a BUY (50%), 2 are a HOLD (50%).

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-0.19 (-14.62%)

6 months 12 days ago

0/6 (0%)

$-0.18 (-13.95%)



6 months 13 days ago

0/2 (0%)

$3.93 (32.56%)



$6.7 (515.38%)


2 years 9 months 22 days ago

2/7 (28.57%)

$3.99 (99.50%)




$5.95 (457.69%)


2 years 11 months 18 days ago

0/4 (0%)

$2.91 (67.05%)


3 years 7 months 27 days ago

0/1 (0%)

$9.43 (110.04%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?

On average it took 103.5 days on average for the stock forecasts to be realized with a an average price target met ratio 13.02

Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?


Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?

Michael Higgins works at LADENBURG and has 6 price targets and 4 ratings on ZYNE

Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?

Lauren Chung with highest potential upside - $30.7

Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?

Sumant Kulkarni with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?